Table 1.

Characteristics of statin users and non-users in patients with inflammatory bowel diseases

Characteristic	Statin users (n = 1,376)	Statin non-users (n = 9,625)	p-value
Current age (in years) [Median (IQR)]	67 (58 – 76)	42 (29 – 56)	< 0.001
Age at first IBD contact (in years) [Median (IQR)]	59 (50 – 68)	36 (24 – 50)	< 0.001
Duration since first IBD contact (in years) [Median (IQR)]	7 (3 – 11)	5 (2 – 9)	< 0.001
Female (%)	45	54	< 0.001
White race (%)	89	85	< 0.001
Type of IBD – ulcerative colitis (%)	62	49	< 0.001
Charlson score [Mean(SD)]	5.8 (3.7)	2.1 (2.7)	< 0.001
Co-existing PSC (%)	2	2	0.68
Medical therapies
Immunomodulator (%)	20	25	< 0.001
Anti-TNF biologics (%)	6	13	< 0.001
Colonoscopy within 3 years (%)	40	35	< 0.001
C-Reactive protein [Median (IQR)] (in mg/L)	5 (2 – 16)	4.4 (2 – 14.4)	0.11
Ever smoker (%)	86	55	< 0.001